Latest News - Earnings & Financials

Wednesday, March 29, 2017 | Earnings & Financials, Allergan

Allergan's CEO Pay Plummets by 80%

After a 2016 that hit some bumps financially -- and one that didn’t feature the Pfizer-Allergan merger the companies had planned on -- Allergan CEO Brent Saunders’ pay is down. Way, way do…

Read the full story

Tuesday, March 21, 2017 | Earnings & Financials, ONL Therapeutics

ONL Therapeutics Receives Nearly $1 Million Grant from National Eye Institute for Continued Advancement of ONL1204 Program

ONL Therapeutics announced that the company has been awarded a Commercialization Readiness Pilot (CRP) grant of approximately $1 million from the National Eye Institute (NEI) to continue advancement o…

Read the full story

Friday, March 17, 2017 | Earnings & Financials, Retina, Aerpio Therapeutics

Aerpio Pharmaceuticals Raises $40 Million

Aerpio Pharmaceuticals, a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced the successful completion of its reverse merger transaction with Aerpi…

Read the full story

Tuesday, March 14, 2017 | Earnings & Financials, Valeant

Ackman Unloads Entire Stake in Valeant

After a long relationship that has seen the rapid rise and massive fall of Valeant’s stock price, Pershing Square Capital Management CEO Bill Ackman stated that his hedge fund has sold all its s…

Read the full story

Friday, March 10, 2017 | Earnings & Financials

Federal Insider Trading Trial Begins for Ex-Angel Player Doug DeCinces

An ex-Angel star who made more than a $1 million in investments related to a friend’s medical-device company appeared in federal court Thursday for the start of his insider-trading trial. A fede…

Read the full story

Wednesday, March 08, 2017 | Earnings & Financials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Provides Update on Products in Development

As part of its fourth quarter and full-year earnings results reporting, Aerie Pharmaceuticals provided updates on several of its products in clinical development, including: Rhopressa (netarsud…

Read the full story

Monday, February 20, 2017 | Earnings & Financials

Essilor to Launch Next Gen Varilux Lens Based on Fresh Approach to Product Development

Essilor is abandoning traditional methods of developing and designing products in favor of an innovative, customer-driven approach that has already yielded a new generation of Varilux progressive lens…

Read the full story

Friday, February 17, 2017 | Dry Eye, Earnings & Financials, Shire

Shire Provides Update on Early Xiidra Sales

As part of its fourth quarter and full-year earnings release on Thursday, Shire provided information about the early sales of its dry eye disease drug Xiidra (lifitegrast), which was launched in Augus…

Read the full story

Tuesday, February 14, 2017 | Earnings & Financials, Retina, Pixium Vision

Pixium Vision Receives NUB Innovation Reimbursement Status-1 for 150 Electrode IRIS II Bionic System in Germany

Pixium Vision announced that the German Institute for the Hospital Remuneration System (InEK) has granted NUB (Neue Untersuchungs- und Behandlungsmethoden) Status-1 for IRIS II, Pixium Vision’s …

Read the full story

Tuesday, February 14, 2017 | Earnings & Financials

Teva Said to Consider Options for Branded Generics Unit

Israeli drugmaker Teva Pharmaceutical Industries is weighing options including a sale of its branded generics products business as it works to reduce debt, according to people familiar with the m…

Read the full story

Monday, February 13, 2017 | Earnings & Financials, Bausch+Lomb

Bausch + Lomb Ends Unilateral Pricing Policy

Bausch + Lomb became the latest contact lens company to move away from its Unilateral Pricing Policy (UPP) with the announcement late Friday that a “competitive imbalance” had forced the c…

Read the full story

Friday, February 10, 2017 | Earnings & Financials, Regeneron Pharmaceuticals

Regeneron Forecasts 2017 US Eylea Sales Growth Below Estimates

Regeneron Pharmaceuticals forecast 2017 U.S. sales growth for its flagship eye drug Eylea that fell short of analysts' estimates, pushing its shares down 2.3 percent in premarket trading. The U.S.…

Read the full story

Monday, February 06, 2017 | Earnings & Financials, Alimera Sciences

Alimera Sciences Announces the Reimbursement of Iluvien in Italy

Alimera Sciences announced that it has received the pricing and reimbursement decree for Iluvien from Agenzia Italiana del Farmaco (AIFA) on January 11, 2017. The decree, published February 2, 2017, i…

Read the full story

Tuesday, January 31, 2017 | Earnings & Financials, Rayner Intraocular Lenses

Phoenix Equity Partners announces investment in Rayner Surgical Group

Phoenix Equity Partners announced an investment in Rayner Surgical Group alongside the current management team, led by Chief Execuive Officer Tim Clover, and a number of the company’s existing s…

Read the full story

Wednesday, January 25, 2017 | Earnings & Financials, Alcon, Novartis

Novartis Considers Spinning Off Alcon Unit

Novartis said it is considering several options for its Alcon unit, including the possibility of separating from the eye care division. The announcement comes after Novartis reported that Alcon’…

Read the full story
Load More